TP53 and cancer: The central role of aberrantly activated EMT pathway in aggressive BRCA is well documented and includes cell diversity, plasticity, metabolic reprogramming, stress response, drug resistance, cancer stem-cell-like phenotypes (26, 27, 49, 51, 52, 85, 86) TP53 tumor suppressor is critical for regulating the features mentioned above.